JAMA Neurology

JAMA Neurology
source
Title	JAMA Neurology
Discipline	Neurology
Abbreviation	JAMA Neurol.
Publisher	American Medical Association
Country	United States
Frequency	Monthly
History	2013–present (retitled from Archives of Neurology)
Impact	30.0
Impact-year	2024

JAMA Neurology is a peer-reviewed medical journal focusing on clinical and translational neurology research, reviews, and commentary. Published by the American Medical Association, it serves a global readership of clinicians, researchers, and policymakers engaged with disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, stroke, and epilepsy. The journal emphasizes evidence-based practice, clinical trials, and guidelines that inform care across hospitals and academic centers like Mayo Clinic, Johns Hopkins Hospital, and Massachusetts General Hospital.

History

The journal traces its lineage to the long-running Archives of Neurology, which connected to institutions such as Harvard Medical School, University of Pennsylvania, and Columbia University. In 2013 the title was changed as part of a broader rebranding by the American Medical Association, aligning it with sister journals including JAMA, JAMA Internal Medicine, and JAMA Oncology. Over time the journal has published landmark reports contemporaneous with large multicenter efforts like the Framingham Heart Study, the Alzheimer's Disease Neuroimaging Initiative, and the National Institute of Neurological Disorders and Stroke trials. Influential contributors have included investigators affiliated with Stanford University School of Medicine, University of California, San Francisco, and University College London.

Scope and Mission

The mission centers on advancing patient care in disorders treated by neurologists at centers such as Cleveland Clinic and UCSF Medical Center. Content spans clinical trials, observational cohorts, diagnostic imaging studies involving modalities developed at Mayo Clinic and Massachusetts General Hospital, and health policy analyses relevant to agencies like the Centers for Disease Control and Prevention and the National Institutes of Health. The journal publishes practice-changing reports comparable in import to trials reported in journals like The Lancet, New England Journal of Medicine, and BMJ while facilitating dissemination to societies including the American Academy of Neurology and international bodies such as the World Health Organization.

Editorial Leadership and Organization

Editorial oversight has been provided by editors-in-chief drawn from leading centers including Brigham and Women's Hospital, Washington University School of Medicine, and University of Toronto. The editorial board assembles associate editors and statistical reviewers from institutions like Yale School of Medicine, University of Oxford, and Imperial College London. Peer review workflows incorporate standards promulgated by organizations such as the International Committee of Medical Journal Editors and the Committee on Publication Ethics. The journal collaborates with trial registries like ClinicalTrials.gov and guideline developers such as the American Academy of Neurology.

Publication and Access

Published monthly by the American Medical Association, the journal offers content in print and online platforms accessed by university libraries at Harvard University, University of California, Los Angeles, and University of Michigan. It adheres to digital archiving practices used by repositories comparable to PubMed Central and indexing services including MEDLINE and Scopus. Open access models have been implemented for selected articles in keeping with funder mandates from organizations like the Wellcome Trust and the National Institutes of Health. The journal issues corrections and retractions following policies advocated by COPE and tracks metrics used by institutions such as Clarivate.

Impact and Reception

The journal is cited frequently in guidance from bodies like the National Institute for Health and Care Excellence and in consensus statements from specialty societies including the European Academy of Neurology. Its impact factor places it among peer publications such as Neurology (journal), Brain (journal), and Annals of Neurology. Media coverage of high-profile articles has appeared in outlets affiliated with institutions like The New York Times, BBC News, and The Washington Post, and findings have influenced clinical practice at tertiary centers including Mount Sinai Hospital and UCSF Medical Center. Critics and advocates alike reference its editorial decisions in discussions at meetings such as the American Academy of Neurology Annual Meeting and symposia at Society for Neuroscience gatherings.

Notable Articles and Contributions

The journal has published randomized trials and observational studies that informed management of ischemic stroke comparable to trials conducted by the European Cooperative Acute Stroke Study groups, diagnostic biomarker reports intersecting with the Alzheimer's Disease Neuroimaging Initiative, and safety data relevant to deep brain stimulation programs pioneered at University of Florida and Cleveland Clinic. Contributions include consensus diagnostic criteria akin to those developed by panels such as the International League Against Epilepsy and large cohort analyses similar to work from the Rotterdam Study. Editorials and reviews have contextualized breakthroughs in genetics from consortia like the International Parkinson Disease Genomics Consortium and therapeutic advances associated with regulatory actions by the Food and Drug Administration and the European Medicines Agency.

Category:Medical journals Category:Neurology